Danli Cao
Harbin, 150081, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Enterolactone mitigates atherosclerosis by facilitating resolution of ferroptosis-associated intimal inflammation via the Keap1/Nrf2/GPX4 pathway.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: November 09, 2025
Enterolactone and THBS1-3TSR synergistically inhibit ovarian cancer and suppress angiogenesis in the tumour microenvironment.
Journal: British journal of pharmacology
Published: January 27, 2025
Multi-level inhibition of SARS-CoV-2 invasion by cannabidiol and epigallocatechin gallate.
Journal: Virology
Published: December 14, 2024
Enterolactone promotes efficacy of gemcitabine on epithelial ovarian cancer and ameliorates gut dysbacteriosis.
Journal: British journal of pharmacology
Published: November 15, 2024
Mechanisms and benefits of phytochemicals as an alternative therapeutic strategy in female cancers.
Journal: Chinese herbal medicines
Published: August 08, 2024
Enterolactone combined with m6A Reader IGF2BP3 inhibits malignant angiogenesis and disease progression in ovarian cancer.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: May 30, 2024
Cannabidiol Inhibits Epithelial Ovarian Cancer: Role of Gut Microbiome.
Journal: Journal of natural products
Published: April 11, 2024
Enterolactone and trabectedin suppress epithelial ovarian cancer synergistically via upregulating THBS1.
Journal: Phytotherapy research : PTR
Published: April 15, 2023
Trabectedin in Cancers: Mechanisms and Clinical Applications.
Journal: Current pharmaceutical design
Published: December 28, 2021
Naringenin suppresses epithelial ovarian cancer by inhibiting proliferation and modulating gut microbiota.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: November 26, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026